TH
TABUTEAU HERRIOT
DELAYED 1 MONTH
Director, Chief Executive Officer, 10% Owner
Axsome Therapeutics, Inc.
Filings
1
Companies
1
Latest
Jun 9, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
82
Axsome Therapeutics, Inc.
TABUTEAU HERRIOT
Director, Chief Executive Officer, 10% Owner
Sale
$12.0M
49,670 sh
Jun 9 9:17 PM
Jun 9, 2026
—
Axsome Therapeutics, Inc.
TABUTEAU HERRIOT
Director, Chief Executive Officer, 10% Owner
Option Exercise
$245.9K
49,670 sh
Jun 9 9:17 PM
Jun 9, 2026